Dr. Eckhart Weidmann memimpin sektor Hematologi di Klinik Nordwest, berspesialisasi dalam pengobatan kelainan darah dengan pengalaman praktik lebih dari 30 tahun.
Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.
Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.
Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Prof. Myriam Ben Arush, seorang spesialis Onkologi Pediatrik yang diakui secara internasional, memimpin Divisi Pediatrik di Rumah Sakit Anak Ruth Rappaport.
Spesialis radioterapi yang berfokus pada kemoterapi leukemia – Dr. Drumea membawa keahlian yang ditargetkan ke Pusat Medis Rambam.
Kepala Hematologi di Pusat Medis Hadassah – Profesor Ben-Yehuda berspesialisasi dalam diagnostik molekuler dan terapi gen untuk kanker darah.
Sebagai Kepala Institut Onkologi sejak 1994, Tamar Jablonski-Perec membawa pengalaman kepemimpinan puluhan tahun untuk kemoterapi leukemia di Hadassah Medical Center.
Dr. Spielberg berspesialisasi dalam kemoterapi leukemia di Assuta Medical Center.
Berspesialisasi dalam onkologi dan radiologi di Pusat Medis Assuta.
Kepala Dokter Pusat Onkologi di Assuta Medical Center – pemimpin dalam perawatan kanker dengan fokus pada pengobatan leukemia.
Spesialis terkemuka Israel dalam imunoterapi kanker paru-paru – Prof. Peled mengepalai Unit Kanker Toraks di Pusat Kanker Davidoff.
Dr. Kim berspesialisasi dalam onkologi dan ginekologi, menawarkan perawatan ahli di Samsung Medical Center.
Profesor Bosch adalah pemimpin yang diakui secara global dalam Leukemia Limfositik Kronis (LLK), memelopori perawatan dan teknologi baru untuk penyakit hematologi.
Prof. Serdar Bedii Omay memiliki lebih dari 65 artikel ilmiah dalam bidang hematologi dan transplantasi sumsum tulang, dengan keahlian dari Fakultas Kedokteran Mie di Jepang.
Dr. Apak berspesialisasi dalam kemoterapi leukemia pediatrik dan transplantasi sumsum tulang, dengan pengalaman lebih dari 30 tahun di Universitas Istanbul-Cerrahpaşa.